Zenas BioPharma, Inc. Common Stock, Capital Shares Reserved for Future Issuance
Zenas BioPharma, Inc. (ZBIO) had Common Stock, Capital Shares Reserved for Future Issuance of 29.71 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 29.71M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 28.18M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 12.48M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 12.31M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 29.71M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 28.18M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 12.48M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 12.31M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 12.44M shares 10-Q · filed 2025-08-12 | |
| 2025-03-31 | 11.94M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 9.46M shares 10-K · filed 2026-03-16 | 9.07M shares 10-K · filed 2025-03-11 |
| 2024-09-30 | 9.08M shares 10-Q · filed 2024-11-12 | |
| 2023-12-31 | 14.03M shares 10-K · filed 2025-03-11 | 14.03M shares 10-Q · filed 2024-11-12 |